Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -273.72% is 445% below its 5-year average of -50.25%, near the low end of its 5-year range (-273.72%–16.73%).
As of the fiscal period ended Tuesday, June 30, 2026. 67.21% below its 12-month average of -163.70%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -273.72%.
RETURN ON EQUITY (ROE)
-273.72%
RETURN ON EQUITY (ROE) AVG TTM
-163.70%
RETURN ON EQUITY (ROE) AVG 3Y
-77.62%
RETURN ON EQUITY (ROE) AVG 5Y
-50.25%
RETURN ON EQUITY (ROE) AVG 10Y
-32.75%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-67.21%
CURRENT VS 3Y AVG
-252.63%
CURRENT VS 5Y AVG
-444.75%
CURRENT VS 10Y AVG
-735.84%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-551.55%
vs the sector median at left
REGENXBIO Inc.
Market Cap
$386.74M
Return on Equity (ROE)
-273.72%
TTM Avg
-163.70%
3Y Avg
-77.62%
5Y Avg
-50.25%
Market Cap
$379.99M
Return on Equity (ROE)
-43.51%
TTM Avg
-51.65%
3Y Avg
-31.19%
5Y Avg
-23.66%
Market Cap
$380.89M
Return on Equity (ROE)
-14.38%
TTM Avg
-22.77%
3Y Avg
-19.17%
5Y Avg
-14.56%
Market Cap
$399.83M
Return on Equity (ROE)
-28.18%
TTM Avg
-0.06%
3Y Avg
10.58%
5Y Avg
10.58%
Market Cap
$375.17M
Return on Equity (ROE)
-38.57%
TTM Avg
-80.22%
3Y Avg
-181.01%
5Y Avg
-130.47%
Market Cap
$373.31M
Return on Equity (ROE)
-92.20%
TTM Avg
-58.64%
3Y Avg
-50.24%
5Y Avg
-28.80%
Market Cap
$399.35M
Return on Equity (ROE)
-43.14%
TTM Avg
2.19%
3Y Avg
15.11%
5Y Avg
15.11%
Market Cap
$372.53M
Return on Equity (ROE)
-54.29%
TTM Avg
-32.16%
3Y Avg
-17.89%
5Y Avg
-29.83%
Market Cap
$437.74M
Return on Equity (ROE)
-66.49%
TTM Avg
134.81%
3Y Avg
90.61%
5Y Avg
61.31%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| REGENXBIO Inc. (RGNX) | $386.74M | -273.72% | -163.70% | -77.62% | -50.25% |
| Zura Bio Limited (ZURA)vs › | $379.99M | -43.51% | -51.65% | -31.19% | -23.66% |
| Orthofix Medical Inc. (OFIX)vs › | $380.89M | -14.38% | -22.77% | -19.17% | -14.56% |
| Shoulder Innovations, Inc. (SI)vs › | $399.83M | -28.18% | -0.06% | 10.58% | 10.58% |
| Canopy Growth Corporation (CGC)vs › | $375.17M | -38.57% | -80.22% | -181.01% | -130.47% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $373.31M | -92.20% | -58.64% | -50.24% | -28.80% |
| Carlsmed, Inc. (CARL)vs › | $399.35M | -43.14% | 2.19% | 15.11% | 15.11% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $372.53M | -54.29% | -32.16% | -17.89% | -29.83% |
| YD Bio Limited Ordinary Shares (YDES)vs › | $437.74M | -66.49% | 134.81% | 90.61% | 61.31% |
| Neurogene Inc. (NGNE)vs › | $402.92M | -51.17% | -29.16% | -33.45% | -16.04% |
ROE
-273.7%
ROA
-50.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -273.72% |
| 2025-12-31 | -188.72% |
| 2025-09-30 | -110.20% |
| 2025-06-30 | -82.17% |
| 2025-03-31 | -57.51% |
| 2024-12-31 | -87.46% |
| 2024-09-30 | -79.23% |
| 2024-06-30 | -69.22% |
| 2024-03-31 | -66.59% |
| 2023-12-31 | -84.52% |
| 2023-09-30 | -71.75% |
| 2023-06-30 | -67.55% |
| 2023-03-31 | -58.11% |
| 2022-12-31 | -54.31% |
| 2022-09-30 | 13.06% |
| 2022-06-30 | 14.39% |
| 2022-03-31 | 14.68% |
| 2021-12-31 | 16.73% |
| 2021-09-30 | -46.04% |
| 2021-06-30 | -28.63% |
| 2021-03-31 | -21.88% |
| 2020-12-31 | -29.45% |
| 2020-09-30 | -22.01% |
| 2020-06-30 | -33.89% |
| 2020-03-31 | -24.41% |
| 2019-12-31 | -21.04% |
| 2019-09-30 | -13.66% |
| 2019-06-30 | -9.82% |
| 2019-03-31 | -7.50% |
| 2018-12-31 | 19.64% |
| 2018-09-30 | 16.12% |
| 2018-06-30 | 24.63% |
| 2018-03-31 | 17.73% |
| 2017-12-31 | -39.98% |
| 2017-09-30 | -39.44% |
| 2017-06-30 | -35.06% |
| 2017-03-31 | -34.85% |
| 2016-12-31 | -38.93% |
| 2016-09-30 | -26.93% |
| 2016-06-30 | -19.23% |
| 2016-03-31 | -14.17% |
| 2015-12-31 | -10.52% |
| 2015-09-30 | -9.00% |
| 2015-06-30 | -17.46% |
| 2015-03-31 | -43.06% |
